-
'A day for French badminton' as Lanier triumph gives them golden double at world champs
-
Kane voted player of the year in Germany
-
Kane voted German footballer of the year
-
Padikkal hundred helps India to 300-5 against Sri Lanka
-
'New season, new trim': Man City star Haaland chops off flowing locks
-
Man City agree deal for Lille star Bouaddi
-
Lanier clinches badminton world title in France's golden double
-
Humanoids break records at Beijing Robot Games
-
After Wildberries, Ukraine launches drone campaign on Russia's Ozon
-
Zelensky rejects rival's call for vote, says would 'split' Ukraine
-
Padikkal, Gill half-centuries take India to 187-3 at tea
-
Zelensky rejects wartime elections, says would 'split' Ukraine
-
Cummins hails 'sharp' Australia as they get back to winning ways
-
'Keep up the spirit': Indonesian teenage 'Superman' joins wildfire fight
-
Bangladesh eye more Australia Tests to hit next level
-
Starc bags 10 as Australia thrash Bangladesh in second Test
-
Thousands expected at Sweden climate demo as election looms
-
Starc heroics see Australia thrash Bangladesh in second Test
-
Starc heroics put Australia on brink of victory over Bangladesh
-
Pegula dethrones Swiatek to book Cincy final against Gauff
-
Austrian mountain town finds niche in AI boom
-
South Korean survivor fights for workplace harassment 'justice'
-
Messi scores but Miami slump continues with loss to Toronto
-
Starc strikes as Bangladesh struggle to stay alive in 2nd Test
-
Sydney marathon unveils medal with wrong stadium
-
Prince Harry: royal misfit making unlikely UK return
-
Macron hosts Saudi's MBS for visit ranging from esports to Mideast
-
Blowing in the wind, humble balloon gets green makeover
-
Australia in control with 146-run first innings lead over Bangladesh
-
Pegula dethrones Swiatek to reach Cincinnati final
-
World No. 3 Pegula beats defending champ Swiatek to reach Cincy final
-
IndyCars zip among iconic Washington landmarks ahead of Freedom 250
-
Wyndham Clark surges clear at BMW Championship
-
Real Madrid snatch late win at Espanyol on Mourinho's return
-
Maresca says Man City must fill Rodri void after Barca switch
-
Real Madrid beat Espanyol in Mourinho's first game on return
-
Canada retaliates as trade war with US escalates
-
Olise helps Bayern past Dortmund in German Supercup
-
Fils dominates Cobolli to book Cincinnati final
-
Coach Rennie hails clinical All Blacks after Springboks Test win
-
Spurs lacked fight in dismal defeat at Brentford says De Zerbi
-
Charlton deliver blow to 'under pressure' Hammers boss Nuno
-
Inter thrash Monza to launch Serie A title defence
-
Carrick keeps calm despite Man Utd misery, big-spending Spurs crushed
-
Shambolic Spurs battered by Brentford
-
Canada's Carney stands up to Trump, despite risks
-
Pogacar wins Vuelta a Espana opening stage
-
Lens hammer Auxerre thanks to Thauvin penalty double
-
Clinical New Zealand shock wasteful South Africa in first Test
-
No singles for Serena, but she joins Alcaraz for US Open
Ghostwriters, polo shirts, and the fall of a landmark pesticide study
A flagship study that declared the weedkiller Roundup posed no serious health risks has been retracted with little fanfare, ending a 25-year saga that exposed how corporate interests can distort scientific research and influence government decision-making.
Published in Regulatory Toxicology and Pharmacology in 2000, the paper ranks in the top 0.1 percent of citations among studies on glyphosate -- the key ingredient in Roundup, owned by agri-giant Monsanto and at the center of cancer lawsuits worth billions of dollars.
In his retraction note last week, the journal's editor-in-chief, Martin van den Berg, cited a litany of serious flaws from failing to include carcinogenicity studies available at the time to undisclosed contributions by Monsanto employees and even questions around financial compensation.
Elsevier, the journal's Dutch publisher, told AFP in a statement that it upholds the "highest standards of rigor and ethics" and that "as soon as the current editor became aware of concerns regarding this paper a matter of months ago, due process began."
But it did not address the fact that concerns date back to 2002, when critics wrote to Elsevier about "conflicts of interest, lack of transparency, and the absence of editorial independence" at the journal, including specific worries about Monsanto.
The matter exploded into public view in 2017, when internal corporate documents released during litigation showed one of Monsanto's own scientists admitting to "ghostwriting."
Harvard University science historian Naomi Oreskes, who co-authored a paper this September detailing the extent of the "fraud" in the 2000 study, told AFP that while she was "very gratified" at the "long overdue" action, but warned that "the scientific community needs better mechanisms to identify and retract fraudulent papers."
"This is completely in alignment with what we were calling them out for at the time," Lynn Goldman, a pediatrician and epidemiologist at GWU who co-signed the 2002 letter, added to AFP.
- Polo shirts -
Two of the paper's three original authors have since died, while first author Gary Williams, a professor at New York Medical College, did not respond to AFP's request for comment.
Monsanto maintains it acted appropriately, and that its product is safe. "Monsanto's involvement with the Williams et al paper did not rise to the level of authorship and was appropriately disclosed in the acknowledgments."
The company declined to comment on internal emails that suggested otherwise, including one in which a Monsanto scientist asked a colleague whether "the team of people" who worked on the Williams paper and another study "could receive Roundup polo shorts as a token of appreciation for a job well done."
Glyphosate was brought to market as a herbicide in the 1970s and initially welcomed as less toxic than DDT.
But its soaring use -- especially after Monsanto introduced glyphosate-tolerant seeds that allowed it to be sprayed widely over crops -- drew increasing scrutiny in the 1990s, making the 2000 paper hugely influential.
According to Oreskes's research, it was cited as supporting evidence for glyphosate's safety by groups ranging from the Canadian Forest Service to the International Court of Justice, the US Congress and the European Parliamentary Research Service.
- Legal interest -
In 2015, the World Health Organization's International Agency for Research on Cancer classified glyphosate as "probably carcinogenic to humans."
Several countries have since moved to restrict or ban its use, including France, which has prohibited household applications. Bayer, which acquired Monsanto, said it would phase out Roundup for US residential use in 2023 in response to growing lawsuits.
Nathan Donley, a scientist with the Center for Biological Diversity, told AFP he does not expect the retraction to sway the US Environmental Protection Agency, now under the pro-agricultural-industry Donald Trump administration, which has thrown its weight behind Bayer in an ongoing Supreme Court case.
But "it could play a role in litigation that is moving forward in the US against the EPA's proposed decision to renew glyphosate," Donley told AFP, adding that European regulators might also take note.
For Donley and others, the deeper concern is that the case may be far from unique.
"I am sure there (are a) lot (of) such ghost-written and undeclared conflict papers in the literature, but they are very difficult to unearth unless one goes really deep in litigation cases," John Ioannidis, a Stanford University professor who founded the field of meta-research told AFP.
P.Stevenson--AMWN